Literature DB >> 17213346

Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

K O Alsaad1, A M Herzenberg.   

Abstract

Diabetic nephropathy is a common cause of end-stage renal disease worldwide. It is characterised by diffuse or nodular glomerulosclerosis, afferent and efferent hyaline arteriolosclerosis, and tubulointerstitial fibrosis and atrophy. Diffuse and nodular diabetic glomerulosclerosis share similar histological features with other clinical conditions. Immunofluorescence and electron microscopy studies, and clinicopathological correlation are essential to differentiate diabetic nephropathy from other conditions that result in diffuse and nodular glomerulosclerosis.

Entities:  

Mesh:

Year:  2007        PMID: 17213346      PMCID: PMC1860608          DOI: 10.1136/jcp.2005.035592

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

Review 1.  Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.

Authors:  R O Estacio; R W Schrier
Journal:  Adv Intern Med       Date:  2001

2.  Diabetic nephropathy: prevention and treatment.

Authors:  H H Parving
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

Review 3.  Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level.

Authors:  Pierre M Ronco; Marie-Alexandra Alyanakian; Beatrice Mougenot; Pierre Aucouturier
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

Review 4.  Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

Authors:  Gerald B Appel; H Terence Cook; Gregory Hageman; J Charles Jennette; Michael Kashgarian; Michael Kirschfink; John D Lambris; Lynne Lanning; Hans U Lutz; Seppo Meri; Noel R Rose; David J Salant; Sanjeev Sethi; Richard J H Smith; William Smoyer; Hope F Tully; Sean P Tully; Patrick Walker; Michael Welsh; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

5.  Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.

Authors:  A M Herzenberg; M Kiaii; A B Magil
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

6.  Renal monoclonal immunoglobulin deposition disease: the disease spectrum.

Authors:  Julie Lin; Glen S Markowitz; Anthony M Valeri; Neeraja Kambham; William H Sherman; Gerald B Appel; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

7.  Glomerulopathies with fibrillary deposits.

Authors:  J A King; R M Culpepper; G R Corey; J A Tucker; G Lajoie; D N Howell
Journal:  Ultrastruct Pathol       Date:  2000 Jan-Feb       Impact factor: 1.094

8.  Glomerular cell number in normal subjects and in type 1 diabetic patients.

Authors:  M W Steffes; D Schmidt; R McCrery; J M Basgen
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

9.  Idiopathic nodular glomerulosclerosis.

Authors:  A M Herzenberg; J K Holden; S Singh; A B Magil
Journal:  Am J Kidney Dis       Date:  1999-09       Impact factor: 8.860

10.  Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.

Authors:  J H Fuller; L K Stevens; S L Wang
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

View more
  68 in total

1.  Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.

Authors:  Masahiko Kure; Marcus G Pezzolesi; G David Poznik; Pisut Katavetin; Jan Skupien; Jonathon S Dunn; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski
Journal:  Mol Genet Metab       Date:  2011-01-14       Impact factor: 4.797

Review 2.  From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Authors:  Ying Qian; Eva Feldman; Subramanian Pennathur; Matthias Kretzler; Frank C Brosius
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

Review 3.  Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?

Authors:  Aowen Zhuang; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

Review 4.  Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis.

Authors:  Di Feng; Clark DuMontier; Martin R Pollak
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-24

5.  Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.

Authors:  Xiaohui Tong; Haijian Ma; Sarah Wambui Amadi; Lingman Ma; Guanzhong Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-06       Impact factor: 3.000

6.  Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy.

Authors:  Susanne B Nicholas; Jun Yuan; Amin Aminzadeh; Keith C Norris; Albert Crum; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2012-07-20       Impact factor: 4.060

7.  Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor β2 Agonist.

Authors:  Steven E Trasino; Xiao-Han Tang; Maria M Shevchuk; Mary E Choi; Lorraine J Gudas
Journal:  J Pharmacol Exp Ther       Date:  2018-07-27       Impact factor: 4.030

Review 8.  Pentoxifylline for Diabetic Nephropathy: an Important Opportunity to Re-purpose an Old Drug?

Authors:  Shelly Bhanot; David J Leehey
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

9.  Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.

Authors:  Cecil Stanley Thompson
Journal:  World J Diabetes       Date:  2013-08-15

Review 10.  Renal endothelial dysfunction in diabetic nephropathy.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.